Palo Alto Investors’s Alimera Sciences ALIM Stock Holding History

Palo Alto Investors’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,919	Closed	-$544K	–	31
2022 Q4	$544K	Hold	200,919	–	–	0.05%	26
2022 Q3	$1.02M	Hold	200,919	–	–	0.08%	27
2022 Q2	$1.1M	Hold	200,919	–	–	0.1%	27
2022 Q1	$1.13M	Hold	200,919	–	–	0.09%	29
2021 Q4	$1.03M	Hold	200,919	–	–	0.07%	32
2021 Q3	$848K	Hold	200,919	–	–	0.05%	36
2021 Q2	$1.83M	Hold	200,919	–	–	0.1%	33
2021 Q1	$1.93M	Hold	200,919	–	–	0.11%	33
2020 Q4	$848K	Hold	200,919	–	–	0.04%	35
2020 Q3	$976K	Hold	200,919	–	–	0.05%	36
2020 Q2	$1.27M	Hold	200,919	–	–	0.08%	32
2020 Q1	$804K	Hold	200,919	–	–	0.07%	27
2019 Q4	$1.52M	Sell	200,919 -1	-0%	-$6	0.08%	27
2019 Q3	$1.71M	Hold	200,920	–	–	0.11%	28
2019 Q2	$2.68M	Hold	200,920	–	–	0.13%	29
2019 Q1	$3.19M	Hold	200,920	–	–	0.13%	29
2018 Q4	$2.16M	Hold	200,920	–	–	0.12%	29
2018 Q3	$2.95M	Hold	200,920	–	–	0.12%	28
2018 Q2	$2.95M	Hold	200,920	–	–	0.12%	28
2018 Q1	$3.1M	Hold	200,920	–	–	0.13%	29
2017 Q4	$4.01M	Hold	200,920	–	–	0.17%	30
2017 Q3	$4.07M	Hold	200,920	–	–	0.17%	28
2017 Q2	$4.19M	Hold	200,920	–	–	0.2%	26
2017 Q1	$4.22M	Hold	200,920	–	–	0.2%	27
2016 Q4	$3.25M	Hold	200,920	–	–	0.19%	28
2016 Q3	$4.49M	Hold	200,920	–	–	0.26%	30
2016 Q2	$3.71M	Hold	200,920	–	–	0.28%	32
2016 Q1	$5.27M	Hold	200,920	–	–	0.41%	28
2015 Q4	$7.29M	Hold	200,920	–	–	0.41%	27
2015 Q3	$6.66M	Hold	200,920	–	–	0.32%	31
2015 Q2	$13.9M	Hold	200,920	–	–	0.62%	29
2015 Q1	$15.1M	Hold	200,920	–	–	0.75%	32
2014 Q4	$16.7M	Sell	200,920 -1,764	-0.9%	-$143K	0.98%	22
2014 Q3	$16.5M	Sell	202,684 -39,648	-16%	-$3.39M	1.23%	20
2014 Q2	$21.7M	Hold	242,332	–	–	1.62%	16
2014 Q1	$28.7M	Hold	242,332	–	–	2.37%	14
2013 Q4	$17.1M	Hold	242,332	–	–	1.59%	17
2013 Q3	$13.7M	Hold	242,332	–	–	1.43%	19
2013 Q2	$17.7M	Buy	+242,332	New	+$14M	2.09%	14

Other funds holding ALIM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Palo Alto Investors's ALIM Position: Q1 2023 in Review

Palo Alto Investors sold out of Alimera Sciences (ALIM) in Q1 2023, closing a stake of 200,919 shares — an estimated $544K sold.

Palo Alto Investors first reported a position in ALIM in Q2 2013 and held it in 39 quarters. The position peaked at $28.7M in Q1 2014. 16 funds tracked by Wall St. Rank hold ALIM as of Q1 2023.

Palo Alto Investors reported no remaining Alimera Sciences position as of Q1 2023 after selling out during the quarter.
Palo Alto Investors sold 200,919 Alimera Sciences shares in Q1 2023, an estimated $544K.
Palo Alto Investors first reported a position in Alimera Sciences in Q2 2013 and held it in 39 quarters.
Palo Alto Investors's Alimera Sciences position peaked at $28.7M in Q1 2014.
16 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2023.

Based on Palo Alto Investors's 13F filing for Q1 2023, filed 15 May 2023.